The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,050.00
Bid: 4,010.00
Ask: 4,040.00
Change: 0.00 (0.00%)
Spread: 30.00 (0.748%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,050.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

16 Sep 2019 16:17

RNS Number : 5022M
North Atlantic Smlr Co Inv Tst PLC
16 September 2019
 

North Atlantic Smaller Companies Investment Trust plc

Half-Yearly Report for the six months ended 31 July 2019

Registered in England and Wales number 1091347

 

 

objective of the company and financial highlights

The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

31 July

31 January

 

 

2019

2019

%

 

(unaudited)

(audited)

Change

Net asset value ("NAV") per 5p Ordinary Share*:

 

 

 

Basic

4,120p

3,710p

 11.1

Diluted

4,118p

 3,708p

11.1

Basic adjusted#

4,255p

 3,776p

12.7

Diluted adjusted#

4,253p

3,774p

12.7

Mid-market price of the 5p Ordinary Shares

3,100p

2,910p

6.5

Discount to diluted net asset value

24.7%

21.5%

 

Discount to diluted adjusted net asset value

 27.1%

22.9%

 

Standard & Poor's 500 Composite Index†

2,451.2

2,062.8

18.8

Russell 2000 Index†

1,295.0

1,143.8

 13.2

Ongoing charges (annualised)

1.1%

1.1%

 

 

* Includes current period.

# Adjusted to reflect Oryx International Growth Fund plc ("Oryx") under the equity method of accounting, which is how the Company previously accounted for its share of Oryx, prior to the adoption of IFRS 10. This is useful to the shareholder as it shows the NAV based on valuing Oryx at NAV. See note 6.

† Sterling adjusted.

 

chief executive's review

During the six months period under review the fully diluted net asset value rose by 12.7% (with Oryx under the equity method of accounting) as compared to a rise in the Sterling Adjusted Standard & Poors Composite Index of 18.8%. The performance however compares very favourably with UK indices where the majority of the Company's assets are located.

Profit for the period amounted to £3,671,000 (31 July 2018 of £2,389,000). The Directors do not intend to declare a dividend at this time, although it is highly likely that a final dividend will be paid in respect of the current financial year.

During the period, the Company purchased for cancellation 132,863 ordinary shares at a favourable discount to NAV which benefits all long term shareholders.

quoted portfolio

The majority of the UK portfolio performed well with Oryx's NAV rising 14.9% and MJ Gleeson rising 16.9%. Other stocks that performed well include Polar Capital, Ergomed, Augean and, in particular, Renalytix which rose over 100%.

This was, however, to some extent offset by the need to totally write off Goals Soccer following a fraud which adversely impacted the net asset value by just under 1%.

Principal new investments during the period were made in Stobart Group, Ergomed and Hargreaves Services.

US quoted portfolio

Our two biggest investments Mountain Commerce and Ambac, both reported satisfactory results during the period but the overall portfolio remains small as a percentage of the total fund.

unquoted portfolio

No new direct investments were made during the period. GAJV and Harwood Leeds were sold. The proceeds were invested in UK equities.

outlook

The Company invested approximately £33m in equities during the period. All the investments were made in businesses trading at a significant discount to private market value and which it is believed will add to the net asset value over the medium term. Nevertheless, the Company remains conservatively invested with net cash of approximately £93m.

Markets as a whole are facing considerable headwinds including a major economic slowdown in Europe in its manufacturing industries and the very realistic possibility of a major China/US trade war which could also spill into Europe. MIFID 2 and a dire IPO market is creating further problems for the UK small cap sector with falling liquidity. However, given the Company's permanent capital structure and substantial cash balances, it remains well placed to benefit from the favourable opportunities which we foresee over the medium term.

 

C H B MillsChief Executive

16 September 2019

 

top ten investmentsas at 31 July 2019

Company

 

 

 

 

 

Fair

 

 

 

Value

% of

 

 

£'000

net assets

US Treasury Bills

US Treasury Stock

82,249

14.1

Oryx International Growth Fund Limited*

UK Listed

57,960

9.9

MJ Gleeson Group plc

UK Listed

42,762

 7.3

Polar Capital Holdings plc

UK Quoted on AIM

40,040

 6.8

Harwood Private Equity Fund IV LP

UK Unquoted

37,338

 6.4

Ten Entertainment Group plc

UK Listed

36,300

6.2

EKF Diagnostics Holdings plc

UK Quoted on AIM

34,104

5.8

Stobart Group Limited

UK Quoted on AIM

21,812

3.7

Augean plc

UK Quoted on AIM

21,275

3.6

Sherwood Holdings Limited

UK Unquoted

18,181

3.1

 

 

392,021

66.9

 

* Traded price under IFRS 10, incorporated in Guernsey.

All investments are valued at fair value.

 

 

interim management report

investment objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation to its shareholders through investing in a portfolio of smaller companies which are principally based in countries bordering the North Atlantic Ocean.

material events

The Board do not consider that there were any material events during the period ended 31 July 2019.

material transactions

There were no material transactions during the period.

risk profile

The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2019. The principal risks arising from the Company's financial instruments are market price risk, including currency risk, interest rate risk and other price risk, liquidity risk and credit risk. The Directors review and agree policies with the Manager, Harwood Capital LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.

The Company does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of counterparties, each having an immaterial effect on the Company's cash flows, should a default happen. The Company assesses the credit worthiness of its debtors from time to time to ensure that they are neither past due or impaired.

To support its investment in unquoted companies, the Company may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.

The Company's exposure to market price risk comprises mainly movements in the value of the Company's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities. The Manager assesses the exposure to market risk when making each investment decision and monitors the overall level of market risk on the whole of the investment portfolio on an ongoing basis.

The functional and presentational currency of the Company is Sterling, and therefore, the Company's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.

The Company invests in equities and other investments that are realisable.

related party

These are listed in note 10 to the half yearly condensed financial transactions statements.

By Order of the Board

 

Peregrine MoncreiffeChairman

16 September 2019

 

 

responsibility statement

The Directors confirm to the best of their knowledge that:

• The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard ("IAS") 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Company; and

• The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and

• The half yearly financial report includes a fair review of the information required by the Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Company during the period and any changes therein.

The half yearly financial report was approved by the Board on 16 September 2019 and the above responsibility statement was signed on its behalf by:

 

Peregrine MoncreiffeChairman

16 September 2019

 

 

condensed statement of comprehensive income (unaudited)

 

 

Six months ended

 

 

Six months ended

 

 

 

 

31 July

 

 

31 July

 

 

 

 

2019

 

 

2018

 

 

 

Revenue

Capital

Total

Revenue

Capital

Total

 

 

£'000

£'000

£'000

£'000

£'000

£'000

 

Income

6,880

 -

6,880

 5,273

 -

 5,273

 

Net gains on investments at fair value

-

53,377

53,377

 -

44,404

44,404

 

Currency exchange gains

 -

188

188

-

129

129

 

total income

 6,880

 53,565

60,445

 5,273

44,533

49,806

 

Expenses

 

 

 

 

 

 

 

Investment management fee (note 10)

 (2,705)

-

(2,705)

 (2,546)

 -

(2,546)

 

Other expenses

(504)

 -

(504)

(338)

 -

(338)

 

return before taxation

3,671

53,565

57,236

2,389

44,533

46,922

 

Taxation

 -

-

-

-

-

-

 

return for the period

 3,671

53,565

57,236

2,389

44,533

46,922

 

earnings per ordinary share (note 5)

 

 

 

 

 

Basic

 

 

400.2p

 

 

325.3p

 

Diluted

 

 

400.1p

 

 

324.9p

 

 

The total column of the statement is the Statement of Comprehensive Income of the Company prepared in accordance with International Financial Reporting Standards ("IFRS"). As adopted by the EU. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice ("SORP") issued by the Association of Investment Companies ("AIC").

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

The accompanying notes are an integral part of these financial statements.

 

 

 

Year ended

 

 

 

31 January

 

 

 

2019

 

 

Revenue

Capital

Total

 

£'000

£'000

£'000

 

11,645

 -

11,645

Income

-

31,095

31,095

Net gains on investments at fair value

 -

271

 271

Currency exchange gains

11,645

 31,366

 43,011

total income

 

 

 

Expenses

(5,091)

 (1,788)

 (6,879)

Investment management fee (note 10)

(714)

-

(714)

Other expenses

5,840

 29,578

35,418

return before taxation

-

-

 -

Taxation

5,840

 29,578

 35,418

return for the period

 

 

 

earnings per ordinary share (note 5)

 

 

246.2p

Basic

 

 

245.8p

Diluted

 

 

 

condensed statement of changes in equity (unaudited)

 

 

Share

Share

 

 

Share

options

premium

Capital

 

capital

reserve

account

reserve

 

£'000

£'000

£'000

£'000

six months ended 31 July 2019

 

 

 

 

31 January 2019

 716

24

1,301

524,316

Total comprehensive income for the period

 -

-

 -

53,565

Shares purchased for cancellation

(7)

-

-

 (3,927)

31 July 2019

709

24

1,301

573,954

six months ended 31 July 2018

 

 

 

 

31 January 2018

721

55

1,301

498,123

Total comprehensive income for the period

-

 -

-

44,533

31 July 2018

721

55

1,301

542,656

year ended 31 January 2019

 

 

 

 

31 January 2018

721

55

 1,301

498,123

Total comprehensive income for the year

 -

 -

 -

 29,578

Shares purchased for cancellation

(5)

 -

 -

 (2,920)

Share option discharge

-

(31)

 -

 (465)

31 January 2019

716

24

1,301

524,316

 

The accompanying notes are an integral part of these financial statements.

 

 

Capital

 

 

 

redemption

Revenue

 

 

reserve

reserve

Total

 

£'000

£'000

£'000

 

 

 

 

six months ended 31 July 2019

154

4,914

531,425

31 January 2019

-

3,671

57,236

Total comprehensive income for the period

7

-

(3,927)

Shares purchased for cancellation

161

 8,585

 584,734

31 July 2019

 

 

 

six months ended 31 July 2018

149

(926)

 499,423

31 January 2018

-

2,389

 46,922

Total comprehensive income for the period

149

 1,463

 546,345

31 July 2018

 

 

 

year ended 31 January 2019

149

(926)

499,423

31 January 2018

-

5,840

35,418

Total comprehensive income for the year

5

-

(2,920)

Shares purchased for cancellation

 -

-

(496)

Share option discharge

154

4,914

531,425

31 January 2019

 

 

 

condensed balance sheet (unaudited)

 

As at

As at

As at

 

31 July

31 July

31 January

 

2019

2018

2019

 

£'000

£'000

£'000

non current assets

 

 

 

Investments at fair value through profit or loss

569,914

526,415

500,696

 

569,914

 526,415

500,696

current assets

 

 

 

Trade and other receivables

 2,961

11,279

 19,623

Cash and cash equivalents

 12,865

11,066

30,669

 

15,826

22,345

50,292

total assets

 585,740

548,760

 550,988

current liabilities

 

 

 

Trade and other payables

(1,006)

 (2,415)

(19,563)

total liabilities

(1,006)

 (2,415)

(19,563)

total assets less current liabilities

584,734

546,345

531,425

net assets

584,734

546,345

531,425

represented by:

 

 

 

Share capital

709

721

 716

Share options reserve

24

55

 24

Share premium account

1,301

 1,301

1,301

Capital reserve

573,954

542,656

 524,316

Capital redemption reserve

161

149

154

Revenue reserve

8,585

 1,463

4,914

total equity attributable to equity holders of the company

584,734

546,345

531,425

net asset value per ordinary share (note 6):

 

 

 

Basic

4,120p

3,787p

3,710p

Diluted

4,118p

 3,782p

3,708p

 

The accompanying notes are an integral part of these financial statements.

 

 

condensed cash flow statement (unaudited)

 

 

 

 

 

Six months

ended

31 July

2019

£'000

Six months

ended

31 July

2018

£'000

 

Year ended

31 January

2019

£'000

cash flows from operating activities

 

 

 

Investment income received

5,502

4,036

9,002

Deposit interest received

13

 5

15

Other income

-

 -

-

Investment Manager's fees and performance fees paid

(4,463)

 (3,654)

 (7,686)

Share based payment - discharge of options

-

 -

 (496)

Other cash payments

(987)

 (847)

(826)

cash generated/(expended) from operations (note 8)

65

 (460)

 9

Taxation paid

 -

-

-

net cash inflow/(outflow) from operating activities

65

(460)

9

cash flows from investing activities

 

 

 

Purchases of investments

(185,307)

(195,357)

(358,127)

Sales of investments

171,297

196,188

380,966

net cash (outflow)/inflow from investing activities

(14,010)

831

22,839

cash flows from financing activities

 

 

 

Repurchase of Ordinary Shares for cancellation

(3,927)

-

(2,920)

net cash outflow from financing activities

(3,927)

-

(2,920)

(decrease)/increase in cash and cash

 

 

 

equivalents for the period

(17,872)

371

19,928

cash and cash equivalents at the start of the period

30,669

10,653

10,653

Revaluation of foreign currency balances

68

42

88

cash and cash equivalents at the end of

 

 

 

the period

12,865

11,066

30,669

 

The accompanying notes are an integral part of these financial statements.

 

 

notes to the financial statements (unaudited)

1. a) basis of accounting

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a company incorporated and registered in England and Wales. The principal activity of the Company is that of an investment trust company within the meaning of Sections 1158/1159 of the Corporation Tax Act 2010.

The condensed financial statements of the Company have been prepared in accordance with International Accounting Standard (IAS) 34 - "Interim Financial Reporting" as adopted by the EU. The accounting policies and methods of computation followed in these half-yearly condensed financial statements are consistent with the most recent annual financial statements for the year ended 31 January 2019 included in the Annual Report.

The financial statements have also been prepared in accordance with the AIC SORP for the financial statements of investment trust companies and venture capital trusts, except to any extent where it is not consistent with the requirements of IFRS.

The financial information contained in this Half-Yearly Report does not constitute statutory accounts as defined in the Companies Act 2006. The financial information for the periods ended 31 July 2019 and 31 July 2018 have not been audited or reviewed by the Company's Auditor. The figure and financial information for the year ended 31 January 2019 are an extract from the latest published audited financial statements, which have been filed with the Registrar of Companies. The report of the Auditor on those financial statements was unqualified and did not contain a statement under either Section 498(2) or 498(3) of the Companies Act 2006.

b) functional currency

The functional currency of the Company is Pounds Sterling because this is the primary economic currency in which the Company operates. The financial statements are presented in Pounds Sterling rounded to the nearest thousand, except where otherwise indicated.

c) significant accounting policies

The accounting policies applied are consistent with those of the Annual Financial Report for the year ended 31 January 2019. Since the year end no new standards have been adopted.

d) segmental reporting

The Directors are of the opinion that the Company is engaged in a single segment of business, being investment business. The Company invests in smaller companies principally based in countries bordering the North Atlantic Ocean.

e) going concern

The financial statements have been prepared on a going concern basis and on the basis that approval as an investment trust company will continue to be met.

The Directors have made an assessment of the Company's ability to continue as a going concern and are satisfied that the Company has the resources to continue in operational existence for the foreseeable future (being a period of at least 12 months from the date these financial statements were approved). Furthermore, the Directors are not aware of any material uncertainties that may cast significant doubt upon the Company's ability to continue as a going concern, having taken into account the liquidity of the Company's investment portfolio and the Company's financial position in respect of its cash flows, borrowing facilities and investment commitments (of which there are none of significance). Therefore, the financial statements have been prepared on the going concern basis.

2. investment management and performance fees

A Performance Fee is only payable if the investment portfolio, including Oryx at the adjusted price, outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds, and is allocated 100% to capital.

An amount would be included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2019. At that date, no Performance Fee, inclusive of VAT, has been accrued for in the accounts (31 July 2018: £nil; 31 January 2019: £1,788,000).

3. taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

During the half year to 31 July 2019, the Company recognised a total charge of £nil (half year to 31 July 2018: £nil, year ended 31 January 2019: £nil), representing irrecoverable withholding tax paid on overseas investment income.

4. dividends

A final dividend for the year ended 31 January 2019 of 30p per Ordinary Share has been declared by the Board, with an Ex date of 31 October 2019 and a payment date of 21 November 2019.

 

 

5. earnings per ordinary share

 

 

Net

Revenue

 

 

Per

 

Net

 Capital

 

Per

 

return

Ordinary

Share

return

Ordinary

Share

 

£'000

Shares

pence

£'000

Shares

pence

six months ended 31 July 2019

 

 

 

 

 

 

Basic return per Share

3,671

14,300,663

25.7

53,565

14,300,663

374.5

Share options*

 -

5,067

 

 -

5,067

 

Diluted return per Share

3,671

14,305,703

25.7

53,565

14,305,703

374.4

six months ended 31 July 2018

 

 

 

 

 

 

Basic return per Share

2,389

14,425,620

16.6

44,533

14,425,620

308.7

Share options*

 -

14,885

 -

14,885

 

 

Diluted return per Share

2,389

14,440,505

16.5

44,533

14,440,505

308.4

year ended 31 January 2019

 

 

 

 

 

 

Basic return per Share

5,840

14,388,359

40.6

29,578

14,388,359

205.6

Share options*

 -

20,895

 

-

20,895

 

Diluted return per Share

5,840

14,409,254

40.5

29,578

14,409,254

205.3

 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Excess of total number of potential shares on Option Conversion over the number that could be issued at the average market price, as calculated in accordance with IAS 33: Earnings per share.

 

 

 

Net

Total

 

 

Per

 

return

Ordinary

Share

 

£'000

Shares

pence

 

 

 

 

six months ended 31 July 2019

57,236

 14,300,663

 400.2

Basic return per Share

-

5,067

 

 Share options*

57,236

 14,305,703

400.1

Diluted return per Share

 

 

 

six months ended 31 July 2018

46,922

14,425,620

325.3

Basic return per Share

-

14,885

 

 Share options*

46,922

14,440,505

324.9

Diluted return per Share

 

 

 

year ended 31 January 2019

35,418

14,388,359

 246.2

Basic return per Share

-

20,895

 

 Share options*

35,418

 14,409,254

 245.8

 Diluted return per Share

 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Excess of total number of potential shares on Option Conversion over the number that could be issued at the average market price, as calculated in accordance with IAS 33: Earnings per share.

 

 

6. net asset value per ordinary share

The basic net asset value per Ordinary Share is based on net assets of £584,734,000 (31 July 2018: £546,345,000; 31 January 2019: £531,425,000) and on 14,192,757 Ordinary Shares (31 July 2018: 14,425,620; 31 January 2019: 14,325,620) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that all 10,000 (31 July 2018: 30,000; 31 January 2019: 10,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 14,202,757 issued Ordinary Shares (31 July 2018: 14,455,620; 31 January 2019: 14,335,620).

During the period, 132,863 Ordinary shares were bought back for cancellation, at a total cost to the Company of £3,900,000.

adjustment for Oryx

The Company has also reported an adjusted net asset value per share using equity accounting, in accordance with its previous method of valuing its investment in Oryx. The Company has chosen to report this net asset value per share to show the difference derived if equity accounting were to be used. Equity accounting permits the use of net asset value pricing for listed assets which in the case of Oryx is higher than its fair value.

The values of Oryx, as at each period end, are as follows:

 

31 July 2019

31 July 2018

31 January 2019

 

£'000

£'000

£'000

Oryx at Fair value (traded price)

57,960

59,940

57,776

Oryx value using Equity Accounting

77,059

67,968

67,270

Increase in net assets using Equity Accounting

19,099

 8,028

9,494

 

 

 

 

31 July 2019

31 July 2018

31 January 2019

Net asset value per Share

 

 

 

- Basic

4,120p

3,787p

3,710p

- Diluted

4,118p

3,782p

3,708p

Net asset value per Share adjusted

 

 

 

- Basic

 4,255p

3,843p

 3,776p

- Diluted

 4,253p

 3,838p

3,774p

 

7. share based remuneration

As at 31 July 2019, there were a total of 10,000 (31 July 2018: 30,000; 31 January 2019: 10,000) options in issue with an estimated fair value of £24,000 under the 2011 options scheme.

8. reconciliation of total return before taxation to cash (expended)/generated from operations

 

Six months

Six months

 

 

ended

ended

Year ended

 

31 July

31 July

31 January

 

2019

2018

2019

 

£'000

£'000

£'000

Total return before taxation

 57,236

 46,922

35,418

Gains on investments

 (53,565)

(44,533)

 (31,366)

Interest reinvested

 (1,050)

 -

(3,500)

Share option discharge

-

 -

(496)

Net return from Subsidiary

 (7)

(7)

(7)

(Increase)/decrease in debtors and accrued income

(365)

(805)

847

Decrease in creditors and accruals

(2,184)

(2,037)

(887)

Cash generated/(expended) from operations

65

 (460)

 9

 

 

 

9. investments

financial assets at fair value through profit or loss

This requires the Company to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy consists of the following three levels:

• Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.

• Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).

• Level 3 - Inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety.

For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability.

The determination of what constitutes 'observable' requires significant judgement by the Company. The Company considers observable data from investments actively traded in organised financial markets, fair value is generally determined by reference to Stock Exchange quoted market bid prices at the close of business on the Balance Sheet date, without adjustment for transaction costs necessary to realise the asset.

 

 

The table below sets out fair value measurements as at the period end, by the level in the fair value hierarchy into which the fair value measurement is categorised.

six months ended 31 July 2019

 

Total

Level 1

Level 2

Level 3

 

£'000

£'000

£'000

£'000

Equity investments

447,339

 372,822

-

74,517

Fixed interest investments

122,575

 82,249

 -

40,326

Total

569,914

455,071

 -

114,843

 

six months ended 31 July 2018

 

Total

Level 1

Level 2

Level 3

 

£'000

£'000

£'000

£'000

Equity investments

397,117

334,188

 -

62,929

Fixed interest investments

129,298

87,089

 -

42,209

Total

526,415

 421,277

 -

105,138

 

year ended 31 January 2019

 

Total

Level 1

Level 2

Level 3

 

£'000

£'000

£'000

£'000

Equity investments

 364,801

 297,472

 -

 67,329

Fixed interest investments

 135,895

90,893

 -

45,002

Total

500,696

 388,365

 -

112,331

 

 

 

reconciliation of level 3 movement - financial assets at 31 July 2019

 

 

 

Equity

Fixed interest

 

Total

investments

investments

 

£'000

£'000

£'000

Opening balance at 31 January 2019

112,331

67,329

45,002

Purchases

10,724

 -

10,724

Sales

(19,579)

(2,953)

(16,626)

Total gains included in gains on investments in the statement of comprehensive income:

 

 

 

- on assets sold

2,045

1,656

389

- on assets held at the end of the period

9,322

8,485

837

Closing balance

114,843

74,517

 40,326

 

unquoted at directors' estimate of fair value

Unquoted investments are valued in accordance with the International Private Equity and Venture Capital Valuation ("IPEV") Guidelines. Their valuation incorporates all factors that market participants would consider in setting a price. The primary valuation techniques employed to value the unquoted investments are earnings multiples, recent transactions and the net asset basis. Valuations in local currency are translated into Sterling at the exchange rate ruling on the Balance Sheet date.

Included within the Statement of Comprehensive Income as at 31 July 2019, is a gain of £9,322,000 relative to the movement in the fair value of the unquoted investments valued using IPEV valuation techniques.

the valuation techniques applied are based on the following assumptions:

Unquoted investments are usually valued by reference to the valuation multiples of similar listed companies or from transactions of similar businesses. Where appropriate discounts are then applied to those comparable multiples to reflect differences in size and liquidity. These enterprise values are then adjusted for net debt to arrive at an equity valuation. Where companies are in compliance with the loan note terms these loans are generally held at par plus accrued interest (where applicable) unless the enterprise value suggests that the debt cannot be recovered.

 

 

10. related party transactions

There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2019.

The Manager, Harwood Capital LLP, is regarded as a related party of the Company. The amounts payable to the Manager and Growth Financial Services Limited in respect of investment management for the six months to 31 July 2019 are as follows:

 

Six months

Six months

 

 

ended

ended

Year ended

 

31 July

31 July

31 January

 

2019

2018

2019

 

£'000

£'000

£'000

Annual fee

2,705

2,546

5,091

Performance fee

 -

 -

1,743

Irrecoverable VAT thereon

 -

 -

 45

 

2,705

 2,546

6,879

 

Fees paid to Directors, for the six months ended 31 July 2019 amounted to £65,000 (six months ended 31 July 2018: £65,000; year ended 31 January 2019: £130,000).

Shareholders should also note any payments made under share based remuneration as disclosed in note 7 to these financial statements.

 

 

shareholder information

 

financial calendar

Announcement of results and annual report May

Annual General Meeting June

Half Yearly figures announced September

Half Yearly Report posted September

share price

The Company's mid-market share price is quoted daily in the Financial Times appearing under "Investment Companies".

It also appears on:

SEAQ Ordinary Shares: NAS

Trustnet: www.trustnet.com

net asset value

The latest net asset value of the Company can be found on the Harwood Capital LLP website:

www.harwoodcapital.co.uk

share dealing

Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.

The Company's registrars are Link Asset Services. In the event of any queries regarding your holding of shares, please contact the registrars on: 0871 664 0300, or by email on enquiries@linkgroup.co.uk

Changes of name or address must be notified to the registrars in writing at:

Link Asset ServicesThe Registry34 Beckenham RoadBeckenhamKent BR3 4TU

 

 

DirectorsPeregrine Moncreiffe (Chairman)Christopher Mills (Chief Executive)Lord Howard of RisingG Walter LoewenbaumSir Charles Wake

ManagerHarwood Capital LLP(Authorised and regulated by the Financial Conduct Authority)6 Stratton StreetMayfairLondon W1J 8LDTelephone: 020 7640 3200

Financial Adviser and StockbrokerWinterflood Investment TrustsThe Atrium BuildingCannon Bridge25 Dowgate HillLondon EC4R 2GA

Registered Office6 Stratton StreetMayfairLondon W1J 8LDTelephone: 020 7640 3200

RegistrarsLink Asset ServicesThe Registry34 Beckenham RoadBeckenhamKent BR3 4TU

AuditorsKPMG LLP15 Canada SquareLondon E14 5GL

Company SecretaryDerringtons LimitedHyde Park House5 Manfred RoadLondon SW15 2RS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR EQLFFKKFFBBL
Date   Source Headline
17th Apr 202410:52 amRNSNet Asset Value(s)
12th Apr 20243:48 pmRNSHolding(s) in Company
8th Apr 20249:42 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202412:45 pmRNSTransaction in Own Shares - Replacement
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20243:55 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 202411:07 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSDividend Declaration
15th Feb 20247:00 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20249:14 amRNSNew Investment: Crest Foods
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20243:32 pmRNSNet Asset Value(s)
27th Dec 20237:00 amRNSDirector Declaration
19th Dec 20237:00 amRNSNet Asset Value(s)
6th Dec 20237:41 amRNSInvestment Update: Ten Entertainment Group Plc
16th Nov 202312:44 pmRNSNet Asset Value(s)
30th Oct 20232:30 pmRNSTransaction in Own Shares
23rd Oct 20232:10 pmRNSTransaction in Own Shares
16th Oct 202312:19 pmRNSNet Asset Value(s)
12th Oct 20238:43 amRNSReplacement: Private Equity Investment Disposal
12th Oct 20237:00 amRNSPrivate Equity investment disposal
9th Oct 20233:02 pmRNSTransaction in Own Shares
15th Sep 20237:00 amRNSHalf-year Report
14th Sep 20231:43 pmRNSNet Asset Value(s)
31st Aug 20234:40 pmRNSCompany Secretary Change
29th Aug 20233:46 pmRNSTransaction in Own Shares - Replacement
29th Aug 20232:49 pmRNSTransaction in Own Shares
21st Aug 20233:07 pmRNSTransaction in Own Shares
16th Aug 20234:15 pmRNSTransaction in Own Shares
15th Aug 202310:03 amRNSNet Asset Value(s)
14th Aug 20232:09 pmRNSTransaction in Own Shares
8th Aug 20234:30 pmRNSTransaction in Own Shares
7th Aug 20234:28 pmRNSTransaction in Own Shares
25th Jul 202312:52 pmRNSNanoco Group Plc
18th Jul 20233:23 pmRNSNet Asset Value(s)
17th Jul 202312:41 pmRNSPortfolio Update
10th Jul 20239:39 amRNSTransaction in Own Shares
3rd Jul 202310:14 amRNSTransaction in Own Shares
30th Jun 202312:17 pmRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSResult of AGM
15th Jun 20231:15 pmRNSNet Asset Value(s)
26th May 20235:10 pmRNSDirectorate Change
22nd May 20231:37 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.